Leukocytes and Peroxiredoxin V in Airway Inflammation
Author Information
Author(s): Krutilina Raisa I, Kropotov Andrei V, Leutenegger Christian, Serikov Vladimir B
Primary Institution: Institute of Cytology Russian Academy of Sciences
Hypothesis
Does inflammation in the airways influence the expression of Peroxiredoxin V (PRXV) in lung epithelial and immune cells?
Conclusion
Inflammation increases expression of PRXV in airways through a shift in cell populations and moderate up-regulation in epithelial cells.
Supporting Evidence
- Bacterial lung inflammation did not change PRXV expression in epithelial cells but increased leukocyte influx.
- Leukocytes were found to be a significant source of PRXV during inflammation.
- PRXV expression was moderately up-regulated in epithelial cells during inflammation.
Takeaway
When the lungs get inflamed, special cells called leukocytes help produce a protein called Peroxiredoxin V that protects the lungs.
Methodology
The study involved in vivo experiments in rats and mice, and in vitro cell culture analyses to assess PRXV expression.
Potential Biases
Potential bias in the interpretation of results due to the specific animal models used.
Limitations
The study primarily focused on specific models of inflammation and may not fully represent all inflammatory conditions.
Participant Demographics
Anesthetized rats and mice were used in the experiments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website